NeueHealth, Inc.
NEUE
$6.79
-$0.0462-0.68%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.21% | 18.68% | 35.52% | 46.92% | 94.45% |
| Total Other Revenue | -28.30% | -28.19% | -18.37% | -7.62% | 16.19% |
| Total Revenue | -17.91% | -19.31% | -9.01% | 1.35% | 26.91% |
| Cost of Revenue | -24.34% | -25.53% | -11.82% | 0.92% | 25.51% |
| Gross Profit | 16.96% | 18.45% | 7.01% | 3.66% | 35.11% |
| SG&A Expenses | -16.23% | -13.87% | -19.91% | -8.23% | -10.58% |
| Depreciation & Amortization | -15.72% | -14.48% | -18.42% | -31.99% | -38.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.27% | -22.62% | -14.04% | -2.23% | 12.92% |
| Operating Income | 55.04% | 45.47% | 42.40% | 21.31% | 38.30% |
| Income Before Tax | 81.21% | 84.19% | 82.33% | -103.63% | -76.72% |
| Income Tax Expenses | 201.04% | 281.86% | 131.07% | 85.10% | 59.98% |
| Earnings from Continuing Operations | 80.78% | 83.74% | 81.16% | -109.72% | -78.89% |
| Earnings from Discontinued Operations | 100.53% | 100.37% | 45.86% | 45.82% | 48.37% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -122.30% | -130.57% | 257.74% | 250.25% | 224.89% |
| Net Income | 86.85% | 88.30% | 77.26% | 26.33% | 30.86% |
| EBIT | 55.04% | 45.47% | 42.40% | 21.31% | 38.30% |
| EBITDA | 58.43% | 47.18% | 41.85% | 12.88% | 36.56% |
| EPS Basic | 83.17% | 85.00% | 75.29% | 26.16% | 30.43% |
| Normalized Basic EPS | -608.60% | -341.74% | 142.89% | 106.63% | 95.58% |
| EPS Diluted | 83.17% | 85.00% | 75.29% | 26.16% | 30.43% |
| Normalized Diluted EPS | -608.60% | -341.74% | 142.89% | 106.63% | 95.58% |
| Average Basic Shares Outstanding | 4.25% | 3.31% | 2.78% | 2.16% | 1.55% |
| Average Diluted Shares Outstanding | 4.25% | 3.31% | 2.78% | 2.16% | 1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |